Published in FEMS Microbiol Lett on June 15, 1998
Multiple factors independently regulate hilA and invasion gene expression in Salmonella enterica serovar typhimurium. J Bacteriol (2000) 2.43
Role of gluconeogenesis and the tricarboxylic acid cycle in the virulence of Salmonella enterica serovar Typhimurium in BALB/c mice. Infect Immun (2006) 1.40
Identification of Mycobacterium avium genes that affect invasion of the intestinal epithelium. Infect Immun (2005) 0.95
A functional cra gene is required for Salmonella enterica serovar typhimurium virulence in BALB/c mice. Infect Immun (2000) 0.94
A Salmonella enterica serovar typhimurium succinate dehydrogenase/fumarate reductase double mutant is avirulent and immunogenic in BALB/c mice. Infect Immun (2007) 0.92
Salmonella enterica serovar Typhimurium mutants unable to convert malate to pyruvate and oxaloacetate are avirulent and immunogenic in BALB/c mice. Infect Immun (2009) 0.89
The interacting Cra and KdpE regulators are involved in the expression of multiple virulence factors in enterohemorrhagic Escherichia coli. J Bacteriol (2013) 0.84
Variable carbon catabolism among Salmonella enterica serovar Typhi isolates. PLoS One (2012) 0.81
Interrelationship between type three secretion system and metabolism in pathogenic bacteria. Front Cell Infect Microbiol (2014) 0.79
Moraxella osloensis gene expression in the slug host Deroceras reticulatum. BMC Microbiol (2008) 0.77
Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans. Crit Care Med (1997) 4.01
Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines. Cancer Res (1984) 3.67
Ribosomes exist in large excess over the apparent demand for protein synthesis during carbon starvation in marine Vibrio sp. strain CCUG 15956. J Bacteriol (1992) 3.07
Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin. Proc Natl Acad Sci U S A (1998) 3.04
Colonization of the streptomycin-treated mouse large intestine by a human fecal Escherichia coli strain: role of growth in mucus. Infect Immun (1988) 2.65
Relationship between the mouse colonizing ability of a human fecal Escherichia coli strain and its ability to bind a specific mouse colonic mucous gel protein. Infect Immun (1983) 2.61
Spatial distribution of Escherichia coli in the mouse large intestine inferred from rRNA in situ hybridization. Infect Immun (1994) 2.40
Relative colonizing abilities of human fecal and K 12 strains of Escherichia coli in the large intestines of streptomycin-treated mice. Eur J Clin Microbiol (1982) 2.39
The risk of endothelial infection in adults with salmonella bacteremia. Ann Intern Med (1978) 2.29
Physiological state of Escherichia coli BJ4 growing in the large intestines of streptomycin-treated mice. J Bacteriol (1995) 2.18
Adhesion of a human fecal Escherichia coli strain to mouse colonic mucus. Infect Immun (1985) 2.07
Schedule-induced mirror responding in the pigeon. J Exp Anal Behav (1973) 2.07
Trends in human leptospirosis in Denmark, 1980 to 2012. Euro Surveill (2015) 2.03
The requirement for potassium for bacteriophage T4 protein and deoxyribonucleic acid synthesis. Virology (1965) 1.97
Escherichia coli F-18 and E. coli K-12 eda mutants do not colonize the streptomycin-treated mouse large intestine. Infect Immun (1996) 1.90
Characterization of the heat shock response and identification of heat shock protein antigens of Borrelia burgdorferi. Infect Immun (1990) 1.88
Intestinal ischemia complicating abdominal aortic surgery. Surgery (1991) 1.87
Colonization of the mouse intestine by an avirulent Salmonella typhimurium strain and its lipopolysaccharide-defective mutants. Infect Immun (1985) 1.83
Roles of motility, chemotaxis, and penetration through and growth in intestinal mucus in the ability of an avirulent strain of Salmonella typhimurium to colonize the large intestine of streptomycin-treated mice. Infect Immun (1988) 1.81
Type 1 pili are not necessary for colonization of the streptomycin-treated mouse large intestine by type 1-piliated Escherichia coli F-18 and E. coli K-12. Infect Immun (1989) 1.81
Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies. Antimicrob Agents Chemother (2000) 1.76
Infective endocarditis caused by gram-negative bacteria: a review of the literature, 1945-1977. Prog Cardiovasc Dis (1980) 1.75
Role of lipopolysaccharide in colonization of the mouse intestine by Salmonella typhimurium studied by in situ hybridization. Infect Immun (1996) 1.74
Spermine inhibits proinflammatory cytokine synthesis in human mononuclear cells: a counterregulatory mechanism that restrains the immune response. J Exp Med (1997) 1.70
Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms. Ann Vasc Surg (1998) 1.68
Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone. J Exp Med (1996) 1.61
Usefulness of seroconversion rates for comparing infection pressures between countries. Epidemiol Infect (2010) 1.53
Colonization of the streptomycin-treated mouse large intestine by a human fecal Escherichia coli strain: role of adhesion to mucosal receptors. Infect Immun (1988) 1.51
The Escherichia coli K-12 gntP gene allows E. coli F-18 to occupy a distinct nutritional niche in the streptomycin-treated mouse large intestine. Infect Immun (1996) 1.50
Identification and characterization of mouse small intestine mucosal receptors for Escherichia coli K-12(K88ab). Infect Immun (1986) 1.47
Inhibition of Escherichia coli precursor-16S rRNA processing by mouse intestinal contents. Environ Microbiol (1999) 1.40
Plasmid transfer in the animal intestine and other dynamic bacterial populations: the role of community structure and environment. Microbiology (1999) 1.40
Presence of K88-specific receptors in porcine ileal mucus is age dependent. Infect Immun (1990) 1.39
In vivo colonization of the mouse large intestine and in vitro penetration of intestinal mucus by an avirulent smooth strain of Salmonella typhimurium and its lipopolysaccharide-deficient mutant. Infect Immun (1987) 1.36
Altered colonizing ability for mouse large intestine of a surface mutant of a human faecal isolate of Escherichia coli. J Gen Microbiol (1983) 1.34
Escherichia coli F-18 phase locked 'on' for expression of type 1 fimbriae is a poor colonizer of the streptomycin-treated mouse large intestine. Microb Pathog (1993) 1.30
Radiochemical method for evaluating the effect of antibiotics on Escherichia coli biofilms. Antimicrob Agents Chemother (1988) 1.29
Characterization and identification of a porcine small intestine mucus receptor for the K88ab fimbrial adhesin. Infect Immun (1991) 1.28
R-Plasmid Transfer to and from Escherichia coli Strains Isolated from Human Fecal Samples. Appl Environ Microbiol (1981) 1.28
Elastase is not sufficient to induce experimental abdominal aortic aneurysms. J Vasc Surg (2001) 1.26
In vivo detection of Escherichia coli type 1 fimbrial expression and phase variation during experimental urinary tract infection. Microbiology (1999) 1.26
Expression of Escherichia coli F-18 type 1 fimbriae in the streptomycin-treated mouse large intestine. Infect Immun (1991) 1.24
Bacterial adhesion to and penetration of intestinal mucus in vitro. Methods Enzymol (1995) 1.23
Role of leuX in Escherichia coli colonization of the streptomycin-treated mouse large intestine. Microb Pathog (1994) 1.22
rpoS gene function is a disadvantage for Escherichia coli BJ4 during competitive colonization of the mouse large intestine. Infect Immun (2000) 1.22
Conditional discrimination performance by pigeons on a response-independent procedure. J Exp Anal Behav (1977) 1.21
The major subunit of Escherichia coli type 1 fimbriae is not required for D-mannose-specific adhesion. Mol Microbiol (1990) 1.21
Pictorial target control of schedule-induced attack in White Carneaux pigeons. J Exp Anal Behav (1974) 1.20
Molecular cloning and primary structure of human chromogranin A (secretory protein I) cDNA. J Biol Chem (1988) 1.16
Variables affecting establishment of schedule-induced attack on pictorial targets in White King pigeons. J Exp Anal Behav (1976) 1.15
Phosphatidylserine found in intestinal mucus serves as a sole source of carbon and nitrogen for salmonellae and Escherichia coli. Infect Immun (1992) 1.14
Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2-year follow-up study of 210 patients. Clin Diagn Lab Immunol (2001) 1.12
Assessment of attack and drinking in White King pigeons on response-independent food schedules. J Exp Anal Behav (1979) 1.12
Regulation of c-myb expression in human neuroblastoma cells during retinoic acid-induced differentiation. Mol Cell Biol (1988) 1.11
Properties of phage T4 messenger RNA synthesized in the absence of protein synthesis. Virology (1972) 1.11
Estimation of growth rates of Escherichia coli BJ4 in streptomycin-treated and previously germfree mice by in situ rRNA hybridization. Clin Diagn Lab Immunol (1999) 1.10
Translational control of vesicular stomatitis virus protein synthesis: isolation of an mRNA-sequestering particle. J Virol (1982) 1.10
Intracellular persistence of Escherichia coli in urinary bladders from mecillinam-treated mice. J Antimicrob Chemother (2005) 1.09
N-acyl-L-homoserine lactone-mediated regulation of the lip secretion system in Serratia liquefaciens MG1. J Bacteriol (2001) 1.08
MLST clustering of Campylobacter jejuni isolates from patients with gastroenteritis, reactive arthritis and Guillain-Barré syndrome. J Appl Microbiol (2009) 1.08
Human neuroblastoma tumor cell lines correspond to the arrested differentiation of chromaffin adrenal medullary neuroblasts. Cell Growth Differ (1990) 1.08
Klebsiella pneumoniae capsule expression is necessary for colonization of large intestines of streptomycin-treated mice. Infect Immun (1999) 1.08
Separation and purification of the mRNAs for vesicular stomatitis virus NS and M proteins. Virology (1979) 1.07
Aggression induced by intermittent positive reinforcement. Neurosci Biobehav Rev (1982) 1.07
Electrophoretic separation of serum lipoproteins in polyacrylamide gel. Clin Chem (1971) 1.05
Nonsurgical management of spontaneous esophageal perforation. JAMA (1978) 1.05
The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms. J Vasc Surg (1999) 1.04
Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012. Euro Surveill (2014) 1.04
Attaching and effacing Escherichia coli isolates from Danish children: clinical significance and microbiological characteristics. Clin Microbiol Infect (2007) 1.03
Piglet ileal mucus contains protein and glycolipid (galactosylceramide) receptors specific for Escherichia coli K88 fimbriae. Infect Immun (1993) 1.03
Comparison of rheumatological and gastrointestinal symptoms after infection with Campylobacter jejuni/coli and enterotoxigenic Escherichia coli. Ann Rheum Dis (2002) 1.01
Evaluation of PCR methods for the diagnosis of pertussis by the European surveillance network for vaccine-preventable diseases (EUVAC.NET). Eur J Clin Microbiol Infect Dis (2013) 1.01
Estimation of incidences of infectious diseases based on antibody measurements. Stat Med (2009) 1.00
The osmotic stress response and virulence in pyelonephritis isolates of Escherichia coli: contributions of RpoS, ProP, ProU and other systems. Microbiology (2001) 1.00
Antibiotic use during pregnancy alters the commensal vaginal microbiota. Clin Microbiol Infect (2013) 1.00